6 - 12 July 2019
These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Poor experiences require national plan for neurology
People in England with neurological conditions are facing long waiting times, poor access to specialists and a lack of personalised care, according to a report/survey by the Neurological Alliance. They call for a National Plan for Neurology and suggest people write to their MPs
Source: Neurological Alliance
MS Trust link: Call for national neurology plan following largest ever survey of people with neurological conditions - MS Trust news item
Regular standing helps symptoms
Opicinumab trial unsuccessful
A trial comparing people taking Avonex (interferon beta 1a) with or without opicinumab (anti-LINGO-1) failed to show an effect on walking and upper limb coordination. Another study, already fully recruited, is starting focussing on people within 20 years of onset - a subgroup who seemed to do best in the original trial.
Source: National MS Society (USA)
MS Trust link: Drugs in development
Natalie's MS journey and how it led to the Black MS Foundation, by Natalie
18 Jan 2022 - 00:00
We caught up with Natalie, Founder of the Black MS Foundation to hear about her multiple sclerosis journey and find out what led her to set up the Foundation.
MS and exercise: part one - a Q&A with physiotherapist, Henriette
14 Jan 2022 - 00:00
In this first blog in a new series, we talk to physiotherapist, Henriette who answers some common questions people with MS may have about exercising.
New study provides strong evidence for role of Epstein Barr virus as a trigger for multiple sclerosis
14 Jan 2022 - 00:00
New research has provided evidence that infection with the Epstein Barr virus acts as a trigger for people to develop MS.
Sign up for updates from us
Keep up-to-date with the latest MS news, explore new research, read the stories of people living with MS, find out practical tips from MS experts, and discover exciting fundraising opportunities.